|
|
|
|
|
|
|
| 1972 | 1 | 2,3 | 137 | On a Clause According to Which Investigators be Restricted from Publishing the Results of Clinical Experimentations with Drugs and on the Legal Responsibility of Investigators (Arising from the Above-Mentioned Clause) | Tadahiro Mituishi |
| 1974 | 2 | 1 | 3 | Concerning consent for clinical trials with drugs and some basic points about its documentation in Japan | Tadahiro Mituishi |
| 1974 | 2 | 2 | 133 | Clinical Evaluation of Drugs used for the Gastric Ulcer－Present and Future | Naokata Shimizu |
| 1974 | 2 | 3 | 327 | New Rulemaking for Protection of Human Subjects Involved in Biomedical Research and Drug Test-Established and Proposed in USA | Haruo Miyano |
| 1975 | 3 | 1 | 3 | Evaluation of Antidepressant Drugs | Masanao Kurihara |
| 1975 | 3 | 2 | 127 | Re-evaluation of Drugs in Japan | Shogo Kuwahara |
| 1975 | 3 | 3 | 281 | Clinical Judement | Takeo Doi |
| 1975 | 3 | 3 | 289 | Clinical Trial and Drug Evaluation for Functional Uterine Bleeding | Koichi Yamamoto |
| 1976 | 4 | 1 | 3 | Methodological Problems in the Clinical Evaluation of Antianxiety Drugs | Hitoshi Itoh |
| 1976 | 4 | 2 | 179 | A Review of Electronic Data Processing of intensive Monitoring Systems in the Detection of Adverse Drug Reaction | Yorio Satoh |
| 1976 | 4 | 3 | 323 | Study on the Clinical Evaluation of Topical Corticosteroids －From the Results of Double-blind Tests in Japan |
Masaru Ishihara |
| 1977 | 5 | 1 | 3 | A Double-blind Controlled Trial Available for Animal Experiment of Cerebrovascular Disease －A brief review － |
Msakuni Kameyama |
| 1977 | 5 | 2 | 177 | A Few Words on Clinical Evaluation of Antihyperlipidemic Drugs | Chikayuki Naito |
| 1977 | 5 | 3 | 457 | Medical Treatment of Cataract | Akira Nakajima |
| 1978 | 6 | 1 | 3 | Drug Treatment for the Aged Patients －A critical review－ | Msakuni Kameyama |
| 1978 | 6 | 2 | 135 | Evaluations of Drugs Used to Treat the Angina Pectoris | Naokata Shimizu |
| 1978 | 6 | 3 | 367 | Reflections on a currently developed method according to which it has been attemped to obtain informed consent in a randomized clinical trial with drugs. This method has recently been tried in Japan | Tadahiro Mituishi |
| 1979 | 7 | 1 | 3 | Drugs and Testicular Toxicity Assessment in Laboratory Animals in Relation to Blood-Tests Barrier | Yoshihito Omori |
| 1979 | 7 | 2 | 195 | The Problems in Clinical Trial of New Drugs involving Women in Pregnancy or Associated Conditions | Koichi Yamamoto |
| 1979 | 7 | 3 | 425 | Influence of Age on Final Global Improvement Rating (FGIR) and Overall Safety Rating of Clinical Drug Experiment | Msakuni Kameyama |
| 1980 | 8 | 1 | 3 | β-blocker and Glaucoma | Akira Nakajima |
| 1980 | 8 | 2 | 307 | Present Status of and Method for Evaluation of Non-steroid Anti-inflammatory Drugs | Yutaka Mizushima |
| 1980 | 8 | 2 | 317 | On the Labeling of Indication and Usage of the Anti-anxiety Drugs －Particulary on the Psycosomatic Diseases－ |
Naokata Shimizu, Sueharu Tsutsui, Hiroyuki Suematsu |
| 1980 | 8 | 3 | 535 | Data Processing on Survival Problem Using Life Table | Yukio Suzuki |
| 1981 | 9 | 1 | 3 | A survey on the protection of human rights of subjects involved in clinical trials with new drugs, on the basis of the results of the enquete study conducted by the Medical Division of the Committee on the Protection of Human Rights of the Japan Federatio | Tadahiro Mitsuishi, Eiko Kurisu, Yorio Satoh |
| 1981 | 9 | 2 | 241 | Retrodiction of Final Global Improvement Rating (FGIR) of Depressive Patients under Antidepressant Therapy by their Background and Initial Checked Points of Doctor's and Patient's Rating Scales on Depression | Masanao Kurihara |
| 1981 | 9 | 3 | 527 | The Lithium Poisoning, Clinical Picture and its Treatment | Shosuke Watanabe, Takashi Ebara |
| 1982 | 10 | 1 | 3 | On 2×2 Contingency Table Analysis and its Application to Clinical Trials | Hiroe Tsubaki |
| 1982 | 10 | 3 | 527 | Measures of Association for the 2×2 Contingency Table and their Application to Clinical Trials | Toshiharu Fujita, Hiroe Tsubaki |
| 1983 | 11 | 1 | 3 | The Ability of Diagnosis, Therapy and Investigation －Phase Ⅱ Study of New Drug Development－ |
Yorio Satoh |
| 1983 | 11 | 2 | 253 | Some Important Issues of Clinical Trials | Chikayuki Naito |
| 1983 | 11 | 3 | 527 | Rating Scales for Dementia－Application for evaluating therapeutic efficacy－ | Hitoshi Itoh, Taeko Takei, Mari Tateyama, et al. |
| 1984 | 12 | 1 | 3 | Drug Affecting Lactation | Yoshihito Omori |
| 1984 | 12 | 2 | 309 | On Some Problems with the Widely Used Statistical Procedures for Comparing Drug Effects | Chihiro Hirotsu |
| 1984 | 12 | 3 | 589 | On Some Problems with the Widely Used Statistical Procedures for Comparing Drug Effects(2) | Chihiro Hirotsu |
| 1985 | 13 | 1 | 3 | Controversies in Clinical Trials, Informed Consent, and Drug Use During Pregnancy | Koichi Yamamoto |
| 1985 | 13 | 2 | 285 | Gene Therapy and Immunopharmacology | Akira Nakajima |
| 1985 | 13 | 3 | 601 | Discrepancy of Results from Different Statistical Tests in Clinical Trials | Toshiharu Fujita, Hiroe Tsubaki |
| 1986 | 14 | 1 | 3 | New Focus on the Current Animal Testing in Preclinical Toxicity Tests －Perspectives on LD50－ |
Yoshihito Omori |
| 1986 | 14 | 2 | 221 | Therapeutic Response of "Brain Artheriosclerosis" | Masanao Kurihara, Toshiharu Fujita |
| 1986 | 14 | 3 | 467 | Some Statistical Problems in Clinical Trials(1) －Test for the Equivalence of Two Drugs－ |
Chihiro Hirotsu |
| 1986 | 14 | 3 | 477 | Multiplicity in Clinical Trials －Especially Problems of the Multiple Comparisons Treatments－ |
Toshiharu Fujita, Hiroe Tsubaki, Yorio Satoh |
| 1986 | 14 | 4 | 707 | Some Statistical Problems in Clinical Trials(2) －Multiplicity of Statistical Tests－ |
Chihiro Hirotsu |
| 1987 | 15 | 1 | 3 | Clincial Evaluation of Anti-dementia Drugs | Msakuni Kameyama |
| 1987 | 15 | 3 | 417 | Adverse Drug Reactions in Clinical Trials | Keiji Ueda |
| 1988 | 16 | 1 | 3 | Revision of the Data Processing System on Drug Evaluation | Toshiharu Fujita, Hiroe Tsubaki |
| 1988 | 16 | 2 | 203 | Clinical Evaluation of Antianxiety Drugs | Sadanori Miura |
| 1988 | 16 | 3 | 411 | Therapeutic Response of "Braini-arteriosclerosis" －Collective Analysis of the Double-Blind Studies－No.2 |
Masanao Kurihara, Toshiharu Fujita |
| 1988 | 16 | 4 | 569 | Informed Consent as a Proof of Participating in the Joint Work －A few comments on clinical trials involving human subjects and on their human rights－ |
Tadahiro Mituishi |
| 1989 | 17 | 1 | 3 | Progress in Clinical Evaluation of Antiarrhythmic Drugs | Kazuo Kato |
| 1989 | 17 | 2 | 171 | Some Problems on Japanese Good Clinical Practice(Draft)(1) | Yorio Satoh |
| 1989 | 17 | 3,4 | 337 | Studies on Side Effects of Drug | Naokata Shimizu, Toshiharu Fujita |
| 1990 | 18 | 1 | 3 | Multiplicity Problem in Comparative Clinical Trial | Yorio Satoh, Chihiro Hirotsu, Hiroe Tsubaki, et al |
| 1990 | 18 | 2 | 245 | Some Problems on Japanise Good Clincial Practice (Draft)(2) | Yorio Satoh |
| 1990 | 18 | 3 | 403 | Some Statistical Problems and Proposals in Comparative Clincial Trials | Chihiro Hirotsu |
| 1990 | 18 | 3 | 425 | Basic Concept of Post-Marketing Surveillance, An Application for the Antihypertensive Drugs | Naokata Shimizu, Yoshihiro Kaneko, Yukio Suzuki |
| 1991 | 19 | 1 | 3 | International Harmonization of Nonclinical Drug Safety Requirements | Yoshihito Omori |
| 1991 | 19 | 2 | 187 | Some Problems in Internationalization of Clinical Trials for New Drug Approval | Chikayuki Naito |
| 1991 | 19 | 2 | 205 | Utility of Drugs and Its Assessments in Clinical Trials | Koichi Yamamoto |
| 1991 | 19 | 4 | 427 | A Guidance for Drug Therapy in the Elderly | Keiji Ueda |
| 1992 | 20 | 1 | 3 | A Few Problems Inherent to the Phase Ⅰ Study in Clinical Evaluation of Drug Efficacy | Chikayuki Naito |
| 1992 | 20 | 3 | 417 | Concepts on "Usefullness" as a Parameter for Global Evaluation of Drug-effects in the Clinical Trial | Naokata Shimizu, Masanao Kurihara, Chikayuki Naito |
| 1993 | 21 | 1 | 3 | Some Theoretical and Psychological Considerations on "FGIR" | Masanao Kurihara |
| 1993 | 21 | 2 | 155 | Pharmacoepidemiology | Naokata Shimizu |
| 1994 | 22 | 1 | 3 | Global Judgement in the Clincial Trial －Especially, on the Problem of Clinical Utility－ | Naokata Shimizu, Yorio Satoh, Robert Temple, et al |
| 1994 | 22 | 1 | 43 | The Tokyo-Yokohama Hypertension Study (TYHS) A Japanese Trial of Prospective Randomized Antihypertensive Treatment | Yoshihiro Kaneko |
| 1994 | 22 | 2,3 | 195 | Clincal Evaluation of Osteoporosis in Internal Medicine | Takuo Fujita |
| 1994 | 22 | 2,3 | 203 | Clinical Evaluation of Osteoporosis | Tetsuo Inoue |
| 1995 | 23 | 1 | 3 | The Present Condition and Problems in the Clinical Evaluation of Anti-HIV Agents | Satoshi Kimura |
| 1995 | 23 | 3 | 489 | On the Recent Topics in the Comparative Clinical Trials | Chihiro Hirotsu |
| 1996 | 24 | 1 | 3 | Information Transduction in Biology and Medicine | Naokata Shimizu |
| 1997 | 24 | 2,3 | 151 | Drug Therapy of Glaucoma | Akira Nakajima |
| 1997 | 25 | 1 | 3 | Drug Therapy of Glaucoma (2) －Glaucoma and Vasoactive Substance (Circulating Hormone)－ |
Akira Nakajima |
| 1998 | 25 | 2,3 | 119 | Constructing a Data Base Useful for a Pharmacological Study | Chihiro Hirotsu |
| 1998 | 25 | 2,3 | 149 | Supply of Information Required for the Proper Use of Drugs | Fumito Tsuchiya |
| 1998 | 26 | 2 | 133 | Clinical Evaluation of Antidementia Drugs | Akira Homma |
| 2001 | 29 | 1 | 167 | Clinical endocrine pharmacology-Including ethnic factors in pharmacodynamics- | Naokata Shimizu |
| 2001 | 29 | 1 | 185 | EBM questioned-A metascientific criticism | Takeo Saio, Chieko Kurihara |
| 2003 | 30 | 2･3 | 353 | Sexual differences and the use of drugs-A review on clinical pharmacology- | Naokata Shimizu |
| 2008 | 36 | 1 | 7 | Deep Brain Stimulation : History, present status and future development | Chikashi Fukaya |
| 2009 | 37 | 1 | 279 | Gender and ethnic variability of the clinical pharmacokinetics of transporter substrates ; －HMG-CoA reductase inhibitors and Angiotensin Ⅱ receptor antagonists－ |
Yoshiko Tomita |
| 2011 | 39 | 1 | 31 | Right to compensation of volunteers for research-related injuries －Comparative study and future perspective in view of global clinical trials－ |
Chieko Kurihara |
| 2013 | 41 | 1 | 241 | Application of non-pharmacological physical treatment to treatment-refractory obsessive-compulsive disorder: A critical viewpoint from a psychiatrist | Toshihide Kuroki |
| 2014 | 41 | 3 | 597 | Regulatory science: An emerging new scientific discipline | A. Alan Moghissi， Roger S. Stough， Takashi Inutsuka，et al． |
| 2017 | 45 | 1 | 35 | Lessons learned from the tragic case in Renne | Yuji Kumagai Takeshi Momma |
| 2019 | 46 | 3･4 | 513 | The end of the DSM era and the rise of pluralism in psychiatry | Toshihide Kuroki |